The article analyzes how social media appeals to obtain the drug daraxonrasib for pancreatic cancer patients, while emotionally engaging, may distract from the need to improve the organization of care and access to more effective treatments. #TumorePancreas #CureOncologiche #RicercaMedica (translated)
